Is Generic Prescribing Acceptable in Epilepsy?
- 1 January 2000
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 23 (3) , 173-182
- https://doi.org/10.2165/00002018-200023030-00001
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- BIO-AVAILABILITY AND DISSOLUTION OF THREE PHENYTOIN PREPARATIONS FOR CHILDRENDevelopmental Medicine and Child Neurology, 2008
- Effects of Switching From Depakene to Generic Valproic Acid on Individuals With Mental RetardationMental Retardation, 1997
- Bioavailability and dissolution of proprietary and generic formulations of phenytoin.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- Double‐Blind Randomized Study Comparing Brand‐Name and Generic Phenytoin MonotherapyEpilepsia, 1992
- Comparison of Steady‐State Blood Levels of Two Carbamazepine FormulationsEpilepsia, 1989
- GENERIC VERSUS BRANDED CARBAMAZEPINEThe Lancet, 1987
- Generic prescribingHuman Psychopharmacology: Clinical and Experimental, 1987
- Serum anticonvulsant concentrations and the risk of drug induced skin eruptions.Journal of Neurology, Neurosurgery & Psychiatry, 1984
- Comparative Bioavailability of Phenytoin from Generic Formulations in the United KingdomEpilepsia, 1982
- BIOAVAILABILTY OF PHENYTOINThe Lancet, 1976